← Evidence map

ArticleNeurocritical care2020

Key Points to Consider When Evaluating Andexxa for Formulary Addition.

Harry Peled et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2020
2021
2022
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31641937